Dermatology
Conference Coverage
Pruritus in elderly patients: Not a diagnosis
“That’s just a symptom with a million etiologies,” Dr. Eric L. Simpson said.
From the Journals
More frequent secukinumab dosing found to benefit overweight psoriasis patients
“The need for individualized treatment in psoriasis is very real,” Dr. Raj Chovatiya said.
From the Journals
Phase 2 studies of novel JAK1 inhibitor for HS show promise
Specifically targeting JAK1 may reduce cytokine signaling involved in HS pathogenesis while limiting JAK2-mediated cytopenias.
Latest News
More than a month after launch, iPLEDGE glitches persist
The latest improvement attempt is a tool created by the Isotretinoin Products Manufacturers Group, the manufacturers responsible for the FDA-...
Latest News
Pioneering test predicts return of malignant melanoma
The test will aid clinicians to identify genuinely low-risk patients diagnosed with an early-stage melanoma, the study’s senior author said.
From the Journals
Antibiotic choices for inpatients with SSTIs vary by race
Clindamycin was more often prescribed for Black patients than White patients.
Latest News
Survey: Medical cannabis use for skin conditions lags behind interest, acceptance
“Dermatologists have an opportunity to educate those who know little in the way of medical cannabis or are skeptic[s].”
News from the FDA/CDC
FDA approves two JAK-1 inhibitors for moderate to severe atopic dermatitis
“It’s big news because a few years ago we didn’t have any systemic treatments that are safer than the classical immunosuppressants.”
Opinion
75-year-old White male presenting with progressive pruritus and a worsening rash
A man with dermatitis herpetiformis, well controlled on dapsone, presented with progressive pruritus and a worsening rash.
Latest News
Hand eczema and atopic dermatitis closely linked
“As clinicians, we sometimes need to rule out a few differentials, including psoriasis and T-cell lymphoma,” Dr. Jacob P. Thyssen said.
From the Journals
Proactive infliximab monitoring found best for sustaining control of inflammatory diseases
Proactive therapeutic drug monitoring with maintenance infliximab proved more effective in sustaining disease control than did standard care in...